Ichikawa W - Search Results

1

Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer.

Ishida H, Fujita K, Akiyama Y, Sunakawa Y, Yamashita K, Mizuno K, Miwa K, Kawara K, Ichikawa W, Ando Y, Saji S, Sasaki Y. Ishida H, et al. Among authors: ichikawa w. Jpn J Clin Oncol. 2011 May;41(5):617-23. doi: 10.1093/jjco/hyr010. Epub 2011 Feb 9. Jpn J Clin Oncol. 2011. PMID: 21310730

2

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.

Ichikawa W, Uetake H, Shirota Y, Yamada H, Takahashi T, Nihei Z, Sugihara K, Sasaki Y, Hirayama R. Ichikawa W, et al. Br J Cancer. 2003 Oct 20;89(8):1486-92. doi: 10.1038/sj.bjc.6601335. Br J Cancer. 2003. PMID: 14562021 Free PMC article. Clinical Trial.

3

Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer.

Ichikawa W, Takahashi T, Suto K, Nihei Z, Shirota Y, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Int J Cancer. 2004 Dec 20;112(6):967-73. doi: 10.1002/ijc.20511. Int J Cancer. 2004. PMID: 15316940

4

Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer.

Ichikawa W, Takahashi T, Suto K, Yamashita T, Nihei Z, Shirota Y, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Br J Cancer. 2004 Oct 4;91(7):1245-50. doi: 10.1038/sj.bjc.6602139. Br J Cancer. 2004. PMID: 15354215 Free PMC article. Clinical Trial.

5

Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.

Ichikawa W, Ooyama A, Toda E, Sugimoto Y, Oka T, Takahashi T, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Cancer Chemother Pharmacol. 2006 Dec;58(6):794-801. doi: 10.1007/s00280-006-0217-6. Epub 2006 Mar 10. Cancer Chemother Pharmacol. 2006. PMID: 16528528

6

Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1.

Ichikawa W, Takahashi T, Suto K, Shirota Y, Nihei Z, Shimizu M, Sasaki Y, Hirayama R. Ichikawa W, et al. Int J Cancer. 2006 Oct 15;119(8):1927-33. doi: 10.1002/ijc.22080. Int J Cancer. 2006. PMID: 16736497

7

Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen.

Ichikawa W, Takahashi T, Suto K, Sasaki Y, Hirayama R. Ichikawa W, et al. Clin Cancer Res. 2006 Jul 1;12(13):3928-34. doi: 10.1158/1078-0432.CCR-05-2665. Clin Cancer Res. 2006. PMID: 16818689 Clinical Trial.

8

Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients.

Ichikawa W, Sasaki Y. Ichikawa W, et al. Ann Oncol. 2006 Nov;17(11):1665-72. doi: 10.1093/annonc/mdl174. Epub 2006 Jul 27. Ann Oncol. 2006. PMID: 16873435 Free article.

9

Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

Ichikawa W, Araki K, Fujita K, Yamamoto W, Endo H, Nagashima F, Tanaka R, Miya T, Kodama K, Sunakawa Y, Narabayashi M, Ando Y, Akiyama Y, Kawara K, Sasaki Y. Ichikawa W, et al. J Natl Cancer Inst. 2008 Feb 6;100(3):224-5; author reply 225. doi: 10.1093/jnci/djm302. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230796 No abstract available.

10

[Pharmacogenetics in fluoropyrimidine chemotherapy].

Ichikawa W, Sasaki Y. Ichikawa W, et al. Gan To Kagaku Ryoho. 2008 Feb;35(2):178-81. Gan To Kagaku Ryoho. 2008. PMID: 18281752 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters